Skip to main content


What it measures:

Measures symptoms on three subscales (Shumaker et al, 1994): 1. Irritative 2. Stress 3. Obstructive/Discomfort Originally studied on community-dwelling women with urinary incontinence, but also used for women with lower urinary tract complaints, attending continence clinics, or on a surgical waiting list for urinary symptoms (Shumaker et al, 1994; Ross et al, 2006). Purpose: To study impact on urinary symptoms on quality of life and ability to participate in everyday activities (Shumaker et al, 1994; Ross et al, 2006). UDI-6 responses predicted whether stress UI, bladder outlet obstruction, and detrusor overactivity were found on urodynamic testing (Ross et al, 2006)

Target Population:

Women with urinary incontinence (UI) specific to lower urinary tract dysfunction and genital prolapse.

Developed to address a gap in UI literature and a lack of a UI-specific measure of health-related QOL.  In the original article, the UDI was intended to be used with the Incontinence Impact Questionnaire (Shumaker et al, 1994).

You Might Also Like...


APTA Pelvic Health: Physical Therapy Management of Functional Constipation in Adults: A 2021 Evidence-Based Clinical Practice Guideline

Jul 1, 2022

This CPG describes the evidence for physical therapist interventions used in the conservative management of adults with functional constipation, a nonpathological

Test & Measure

3-Incontinence Questionnaire (3-IQ)

Self-administered brief questionnaire with purpose of differentiating between stress and urge urinary incontinence in women.

Test & Measure

Pelvic Floor Distress Inventory (PFDI-20)

Measures pelvic floor disorders.